Atlas Trials

Study to Evaluate NA-NOSE for Monitoring and Detecting Recurrence in Early Stage Lung Cancer

Clinical trial NCT01840150 · COMPLETED

Trial details

NCT number
NCT01840150
Sponsor
Fox Chase Cancer Center
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Stage IA Non-small Cell Lung CancerStage IB Non-small Cell Lung CancerStage IIA Non-small Cell Lung CancerStage IIB Non-small Cell Lung Cancer
Start date
2012-08-23
Primary completion
2018-03-22
Enrollment
41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.